Roivant Sciences Ltd. — Director's Dealing 2023

Oct 3, 2023

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Roivant Sciences Ltd. (ROIV)
CIK: 0001635088
Period of Report: 2023-09-28

Reporting Person: MANCHESTER KEITH S (N/A)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2023-09-28	Common Shares	S	2285783	$11.55	Disposed	25724561	Indirect
2023-09-28	Common Shares	S	3059368	$11.55	Disposed	34430591	Indirect
2023-09-28	Common Shares	S	1104599	$11.55	Disposed	12431330	Indirect
2023-09-28	Common Shares	S	446394	$11.55	Disposed	5023787	Indirect

Footnotes

F1: The reporting person is a shareholder of each of QVT Roiv Hldgs Onshore Ltd., QVT Deferred Compensation Holdings Ltd., QVT P&E Roiv Hldgs Ltd. and QVT Financial Investment Cayman Ltd. (the "QVT Entities") but does not have any voting or investment control over the QVT Entities. The reporting person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these Common Shares in this report shall not be deemed an admission of beneficial ownership of all of the reported Common Shares for purposes of Section 16 or for any other purpose.